BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Wang CY, Chao YJ, Chen YL, Wang TW, Phan NN, Hsu HP, Shan YS, Lai MD. Upregulation of peroxisome proliferator-activated receptor-α and the lipid metabolism pathway promotes carcinogenesis of ampullary cancer. Int J Med Sci 2021;18:256-69. [PMID: 33390794 DOI: 10.7150/ijms.48123] [Cited by in Crossref: 4] [Cited by in F6Publishing: 5] [Article Influence: 4.0] [Reference Citation Analysis]
Number Citing Articles
1 Chiao CC, Liu YH, Phan NN, An Ton NT, Ta HDK, Anuraga G, Minh Xuan DT, Fitriani F, Putri Hermanto EM, Athoillah M, Andriani V, Ajiningrum PS, Wu YF, Lee KH, Chuang JY, Wang CY, Kao TJ. Prognostic and Genomic Analysis of Proteasome 20S Subunit Alpha (PSMA) Family Members in Breast Cancer. Diagnostics (Basel) 2021;11:2220. [PMID: 34943457 DOI: 10.3390/diagnostics11122220] [Reference Citation Analysis]
2 Duan Z, Zhang Y, Tang Y, Gao R, Bao J, Liang B. Adjuvant therapy for periampullary carcinoma and the significance of histopathological typing: A systematic review. Transl Oncol 2022;20:101414. [PMID: 35397420 DOI: 10.1016/j.tranon.2022.101414] [Reference Citation Analysis]
3 Chou CW, Hsieh YH, Ku SC, Shen WJ, Anuraga G, Khoa Ta HD, Lee KH, Lee YC, Lin CH, Wang CY, Wang WJ. Potential Prognostic Biomarkers of OSBPL Family Genes in Patients with Pancreatic Ductal Adenocarcinoma. Biomedicines 2021;9:1601. [PMID: 34829830 DOI: 10.3390/biomedicines9111601] [Reference Citation Analysis]
4 Wu YH, Yeh IJ, Phan NN, Yen MC, Hung JH, Chiao CC, Chen CF, Sun Z, Hsu HP, Wang CY, Lai MD. Gene signatures and potential therapeutic targets of Middle East respiratory syndrome coronavirus (MERS-CoV)-infected human lung adenocarcinoma epithelial cells. J Microbiol Immunol Infect 2021:S1684-1182(21)00058-X. [PMID: 34176764 DOI: 10.1016/j.jmii.2021.03.007] [Reference Citation Analysis]
5 Khoa Ta HD, Tang WC, Phan NN, Anuraga G, Hou SY, Chiao CC, Liu YH, Wu YF, Lee KH, Wang CY. Analysis of LAGEs Family Gene Signature and Prognostic Relevance in Breast Cancer. Diagnostics (Basel) 2021;11:726. [PMID: 33921749 DOI: 10.3390/diagnostics11040726] [Cited by in Crossref: 3] [Cited by in F6Publishing: 5] [Article Influence: 3.0] [Reference Citation Analysis]
6 Muzio G, Barrera G, Pizzimenti S. Peroxisome Proliferator-Activated Receptors (PPARs) and Oxidative Stress in Physiological Conditions and in Cancer. Antioxidants (Basel) 2021;10:1734. [PMID: 34829605 DOI: 10.3390/antiox10111734] [Reference Citation Analysis]
7 Prayugo FB, Kao TJ, Anuraga G, Ta HDK, Chuang JY, Lin LC, Wu YF, Wang CY, Lee KH. Expression Profiles and Prognostic Value of FABPs in Colorectal Adenocarcinomas. Biomedicines 2021;9:1460. [PMID: 34680577 DOI: 10.3390/biomedicines9101460] [Reference Citation Analysis]
8 Xuan DTM, Wu CC, Kao TJ, Ta HDK, Anuraga G, Andriani V, Athoillah M, Chiao CC, Wu YF, Lee KH, Wang CY, Chuang JY. Prognostic and immune infiltration signatures of proteasome 26S subunit, non-ATPase (PSMD) family genes in breast cancer patients. Aging (Albany NY) 2021;13:24882-913. [PMID: 34839279 DOI: 10.18632/aging.203722] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
9 Kao TJ, Wu CC, Phan NN, Liu YH, Ta HDK, Anuraga G, Wu YF, Lee KH, Chuang JY, Wang CY. Prognoses and genomic analyses of proteasome 26S subunit, ATPase (PSMC) family genes in clinical breast cancer. Aging (Albany NY) 2021;13:17970. [PMID: 34329194 DOI: 10.18632/aging.203345] [Cited by in F6Publishing: 2] [Reference Citation Analysis]
10 Anuraga G, Tang WC, Phan NN, Ta HDK, Liu YH, Wu YF, Lee KH, Wang CY. Comprehensive Analysis of Prognostic and Genetic Signatures for General Transcription Factor III (GTF3) in Clinical Colorectal Cancer Patients Using Bioinformatics Approaches. Curr Issues Mol Biol 2021;43:2. [PMID: 33925358 DOI: 10.3390/cimb43010002] [Cited by in Crossref: 3] [Cited by in F6Publishing: 5] [Article Influence: 3.0] [Reference Citation Analysis]
11 Gao W, Niu L, Chen W, Zhang Y, Huang W. Integrative Analysis of the Expression Levels and Prognostic Values for NEK Family Members in Breast Cancer. Front Genet 2022;13:798170. [DOI: 10.3389/fgene.2022.798170] [Reference Citation Analysis]